Drug:
Reaction: DRUG INEFFECTIVE
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555316 |
US |
||
Pruritus, Urticaria, Drug ineffective, |
||||
OMALIZUMAB, |
||||
| 2 | 26555318 |
EU |
26 | 1 |
Ileostomy, Procedural haemorrhage, Cardiac failure chronic, Abdominal pain lower, Drug ineffective, |
||||
INFLIXIMAB, GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, UPADACITINIB, UPADACITINIB, |
||||
| 3 | 26555326 |
US |
80 | 1 |
Inappropriate schedule of product administration, Drug ineffective, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, |
||||
| 4 | 26555363 |
|||
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 5 | 26555371 |
US |
39 | 2 |
Drug ineffective, |
||||
MIRIKIZUMAB-MRKZ, |
||||
| 6 | 26555389 |
US |
1 | |
Oxygen saturation decreased, Dyspnoea, Cough, Asthenia, Wrong technique in device usage process, Drug ineffective, Product complaint, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 7 | 26555393 |
US |
1 | |
Drug ineffective, |
||||
DIMETHYL FUMARATE, |
||||
| 8 | 26555418 |
US |
80 | 1 |
Inappropriate schedule of product administration, Drug ineffective, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, |
||||
| 9 | 26555468 |
EU |
60 | 2 |
Philadelphia chromosome positive, Drug ineffective, |
||||
NILOTINIB, |
||||
| 10 | 26555472 |
US |
||
Product quality issue, Drug ineffective, |
||||
RABEPRAZOLE SODIUM, RABEPRAZOLE, |
||||
| 11 | 26555480 |
|||
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 12 | 26555503 |
US |
1 | |
Drug ineffective, Wrong product administered, No adverse event, |
||||
FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, |
||||
| 13 | 26555504 |
US |
2 | |
Drug ineffective, No adverse event, |
||||
FEXOFENADINE HYDROCHLORIDE, |
||||
| 14 | 26555548 |
US |
55 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 15 | 26555552 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 16 | 26555554 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 17 | 26555558 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 18 | 26555559 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 19 | 26555560 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 20 | 26555577 |
EU |
64 | 2 |
Haematotoxicity, Drug ineffective, Mucosal inflammation, |
||||
CISPLATIN, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CARFILZOMIB, LENALIDOMIDE, ACYCLOVIR, ZOLEDRONIC ACID, |
||||
| 21 | 26555578 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 22 | 26555580 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 23 | 26555581 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 24 | 26555586 |
US |
36 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 25 | 26555589 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 26 | 26555590 |
US |
||
Drug ineffective, Drug ineffective for unapproved indication, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 27 | 26555591 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 28 | 26555592 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 29 | 26555593 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 30 | 26555596 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 31 | 26555597 |
US |
||
Drug ineffective, Drug effect less than expected, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 32 | 26555598 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 33 | 26555601 |
US |
79 | 2 |
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 34 | 26555629 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 35 | 26555638 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 36 | 26555640 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 37 | 26555655 |
RU |
51 | 1 |
Rebound effect, Drug ineffective, VEXAS syndrome, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AZACITIDINE, AZACITIDINE FOR, METHYLPREDNISOLONE, METHYLPREDNISOLONE, CYCLOSPORINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, BUSULFAN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 38 | 26555656 |
CA |
8 | 1 |
Accidental underdose, Anticoagulation drug level below therapeutic, Drug ineffective, |
||||
RIVAROXABAN, WARFARIN, |
||||
| 39 | 26555658 |
CA |
15 | 2 |
Abdominal pain, Acrochordon, Adrenal insufficiency, Arthralgia, Arthritis, Asthenia, Autoimmune hepatitis, Chronic gastritis, Colitis, Colon cancer, Crohn^s disease, Decreased appetite, Diarrhoea, Drug hypersensitivity, Dysplasia, Electrocardiogram QT prolonged, Electrolyte imbalance, Enteritis, Fall, Fatigue, Haemorrhage, Ileal ulcer, Increased tendency to bruise, Iron deficiency anaemia, Nausea, Portal hypertension, Portal vein thrombosis, Raynaud^s phenomenon, Sinusitis, Varices oesophageal, Drug ineffective, Drug ineffective, |
||||
RIVAROXABAN, ADALIMUMAB, CARVEDILOL, VEDOLIZUMAB, INFLIXIMAB, USTEKINUMAB, AZATHIOPRINE, |
||||
| 40 | 26555666 |
US |
1 | |
Drug ineffective, Condition aggravated, Inflammation, |
||||
INFLIXIMAB, |
||||
| 41 | 26555690 |
64 | ||
Psoriasis, Mental status changes, Depression, Stress, Drug ineffective, Off label use, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, UPADACITINIB, |
||||
| 42 | 26555708 |
US |
61 | 2 |
Urinary retention, Drug ineffective, |
||||
SOLIFENACIN SUCCIATE, SOLIFENACIN SUCCINATE, |
||||
| 43 | 26555734 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 44 | 26555735 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 45 | 26555736 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 46 | 26555737 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 47 | 26555773 |
MX |
39 | |
Drug ineffective, |
||||
LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, CEFTRIAXONE, CEFTRIAXONE SODIUM, ACYCLOVIR, METHYLPREDNISOLONE, PROPOFOL, PROPOFOL, |
||||
| 48 | 26555774 |
69 | 1 | |
Drug resistance, Drug ineffective, |
||||
SERTRALINE, MELATONIN, MIRTAZAPINE, BUPROPION, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 49 | 26555777 |
US |
75 | 1 |
Thyrotoxic crisis, Ventricular tachycardia, Drug ineffective, Thyroiditis, Cardiac arrest, Cardiac failure, Shock, Multiple organ dysfunction syndrome, |
||||
PROPRANOLOL HYDROCHLORIDE, METHIMAZOLE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 50 | 26555795 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 51 | 26555796 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 52 | 26555797 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 53 | 26555798 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 54 | 26555799 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 55 | 26555800 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 56 | 26555802 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 57 | 26555803 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 58 | 26555806 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 59 | 26555807 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 60 | 26555814 |
|||
Drug ineffective, Product substitution issue, |
||||
CHLORTHALIDONE, LACOSAMIDE, PRAMIPEXOLE, |
||||
| 61 | 26555817 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 62 | 26555818 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 63 | 26555819 |
US |
40 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 64 | 26555821 |
US |
30 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 65 | 26555823 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 66 | 26555825 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 67 | 26555826 |
US |
38 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 68 | 26555827 |
US |
33 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 69 | 26555828 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 70 | 26555829 |
US |
52 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 71 | 26555830 |
US |
44 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 72 | 26555857 |
US |
40 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 73 | 26555858 |
US |
40 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 74 | 26555860 |
US |
40 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 75 | 26555861 |
US |
40 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 76 | 26555871 |
US |
2 | |
Drug ineffective, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 77 | 26555873 |
US |
2 | |
Drug ineffective, Lactose intolerance, Gluten sensitivity, |
||||
METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE SULFATE, |
||||
| 78 | 26555886 |
US |
||
Pruritus, Hypersensitivity, Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 79 | 26555887 |
US |
68 | |
Drug ineffective, Off label use, Headache, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 80 | 26555892 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 81 | 26555893 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 82 | 26555894 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 83 | 26555899 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 84 | 26555902 |
US |
37 | |
Disturbance in attention, Dyspnoea, Migraine, Hypoaesthesia, Asthenia, Headache, Malaise, Dizziness, Discomfort, Anxiety, Drug ineffective, Incorrect route of product administration, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 85 | 26555903 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 86 | 26555911 |
US |
86 | 1 |
Parkinson^s disease, Cough, Drug ineffective, |
||||
LEVODOPA, |
||||
| 87 | 26555914 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 88 | 26555915 |
US |
25 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 89 | 26555916 |
US |
42 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 90 | 26555917 |
US |
32 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 91 | 26555918 |
US |
30 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 92 | 26555919 |
US |
37 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 93 | 26555920 |
US |
31 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 94 | 26555926 |
US |
32 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 95 | 26555927 |
US |
46 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 96 | 26555930 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 97 | 26555931 |
US |
30 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 98 | 26555934 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 99 | 26555935 |
US |
44 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 100 | 26555939 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28